Randomized, controlled clinical trial of glargine insulin versus ultralente insulin in type 1 diabetes

被引：0
|
作者：
Kudva, Y
Basu, A
Jenkins, G
Pons, G
Quandt, L
Gebel, J
Vogelsang, D
Smith, S
Isley, W
Rizza, R
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A133 / A133
页数：1
相关论文
共 50 条
  • [1] Randomized controlled clinical trial of glargine versus ultralente insulin in the treatment of type 1 diabetes
    Kudva, YC
    Basu, A
    Jenkins, GD
    Pons, GM
    Quandt, LL
    Gebel, JA
    Vogelsang, DA
    Smith, SA
    Rizza, RA
    Isley, WL
    DIABETES CARE, 2005, 28 (01) : 10 - 14
  • [2] A randomized, multicentre trial of insulin glargine versus NPH insulin in people with Type 1 diabetes.
    Home, P
    DIABETOLOGIA, 2002, 45 : A258 - A258
  • [3] Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes - A randomized trial
    Heine, RJ
    Van Gaal, LF
    Johns, D
    Mihm, MJ
    Widel, MH
    Brodows, RG
    ANNALS OF INTERNAL MEDICINE, 2005, 143 (08) : 559 - 569
  • [4] Decreased, nocturnal glycemic variation with insulin glargine compared to insulin ultralente in a randomized, crossover clinical trial
    Kudva, YC
    Basu, A
    Jenkins, G
    Pons, G
    Quandt, L
    Gebel, J
    Vogelsang, D
    Rizza, R
    Smith, S
    Isley, W
    DIABETOLOGIA, 2004, 47 : A306 - A307
  • [5] A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes
    Home, PD
    Rosskamp, R
    Forjanic-Klapproth, J
    Dressler, A
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (06) : 545 - 553
  • [6] A Randomized Clinical Trial of Insulin Glargine and Aspart, Compared to NPH and Regular Insulin in Children with Type 1 Diabetes Mellitus
    Rostami, Parastoo
    Setoodeh, Aria
    Rabbani, Ali
    Nakhaei-Moghadam, Maryam
    Najmi-Varzaneh, Farnaz
    Rezaei, Nima
    IRANIAN JOURNAL OF PEDIATRICS, 2014, 24 (02) : 173 - 178
  • [7] Insulin glargine versus NPH insulin in patients with type 1 diabetes
    Ratner, R
    DRUGS OF TODAY, 2003, 39 (11) : 867 - 876
  • [8] Efficacy and safety of insulin glargine in subjects with type 1 diabetes: A 28 week randomized, NPH insulin-controlled trial
    Ratner, RE
    Hirsch, IB
    Mecca, TE
    Wilson, CA
    DIABETES, 1999, 48 : A120 - A120
  • [9] Efficacy and safety of insulin glargine in type 1 diabetes: A 28 week randomized, NPH-insulin controlled trial.
    Ratner, RE
    Hirsch, IB
    Mecca, TE
    Wilson, CA
    DIABETOLOGIA, 1999, 42 : A234 - A234
  • [10] Basal insulin peglispro versus insulin glargine in insulin-naive type 2 diabetes: IMAGINE 2 randomized trial
    Davies, M. J.
    Russell-Jones, D.
    Selam, J. -L.
    Bailey, T. S.
    Kerenyi, Z.
    Luo, J.
    Bue-Valleskey, J.
    Ivanyi, T.
    Hartman, M. L.
    Jacobson, J. G.
    Jacober, S. J.
    DIABETES OBESITY & METABOLISM, 2016, 18 (11): : 1055 - 1064
12345